Literature DB >> 16835740

Nosocomial transmission in simultaneous outbreaks of hepatitis C and B virus infections in a hemodialysis center.

L A Kondili1, D Genovese, C Argentini, P Chionne, P Toscani, R Fabro, R Cocconi, M Rapicetta.   

Abstract

Reported here are details of a simultaneous outbreak of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections that occurred in a hemodialysis centre in northern Italy, with three patients seroconverting for HBsAg and four patients seroconverting for HCV antibodies. Phylogenetic analysis of the E2 region of the isolates from HCV-seroconverted patients showed the sequences were grouped in the same distinct branch as in a chronically HCV-infected patient, suggesting that the chronically infected patient was the index case. For the patients with HBV infection, phylogenetic analysis showed strong clustering among the sequences of the three patients who seroconverted to HBsAg and no relatedness between them and the sequences of patients chronically infected with HBV. For one of the patients who seroconverted to HBsAg, the last test with negative results for HBV markers had been performed 18 months prior to HBsAg seroconversion. This patient may have been previously infected with HBV and is presumed to be the source of the outbreak. This report emphasizes the importance of using universal precaution measures and HBV vaccination to prevent the transmission of viral hepatitis among chronic hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16835740     DOI: 10.1007/s10096-006-0162-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  MEGA2: molecular evolutionary genetics analysis software.

Authors:  S Kumar; K Tamura; I B Jakobsen; M Nei
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

2.  National surveillance of dialysis associated diseases in the United States, 1995.

Authors:  J I Tokars; E R Miller; M J Alter; M J Arduino
Journal:  ASAIO J       Date:  1998 Jan-Feb       Impact factor: 2.872

3.  Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit.

Authors:  X Forns; P Fernández-Llama; M Pons; J Costa; S Ampurdanés; F X López-Labrador; E Olmedo; J López-Pedret; A Darnell; L Revert; J M Sánchez-Tapias; J Rodés
Journal:  Nephrol Dial Transplant       Date:  1997-04       Impact factor: 5.992

4.  Detection of hepatitis C virus in dialysate and in blood ultrafiltrate of HCV-positive patients.

Authors:  M Sampietro; G Graziani; S Badalamenti; S Salvadori; R Caldarelli; G Como; G Fiorelli
Journal:  Nephron       Date:  1994       Impact factor: 2.847

Review 5.  Genetic variability in hepatitis B viruses.

Authors:  Karin Kidd-Ljunggren; Yuzo Miyakawa; Alistair H Kidd
Journal:  J Gen Virol       Date:  2002-06       Impact factor: 3.891

6.  A twelve year natural history of hepatitis C virus infection in hemodialyzed patients.

Authors:  N Simon; A M Couroucé; N Lemarrec; C Trépo; S Ducamp
Journal:  Kidney Int       Date:  1994-08       Impact factor: 10.612

7.  Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group.

Authors:  M Jadoul; C Cornu; C van Ypersele de Strihou
Journal:  Kidney Int       Date:  1993-12       Impact factor: 10.612

8.  A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients.

Authors:  S Günther; B C Li; S Miska; D H Krüger; H Meisel; H Will
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

9.  Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis.

Authors:  D Genovese; S Dettori; C Argentini; U Villano; P Chionne; M Angelico; M Rapicetta
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 10.  Genetic diversity and evolution of hepatitis C virus--15 years on.

Authors:  Peter Simmonds
Journal:  J Gen Virol       Date:  2004-11       Impact factor: 3.891

View more
  5 in total

1.  A shield against a monster: Hepatitis C in hemodialysis patients.

Authors:  Seyed-Moayed Alavian
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

2.  Guidelines for the detection of a common source of hepatitis B virus infections.

Authors:  Mahmoud Reza Pourkarim; Marc Van Ranst
Journal:  Hepat Mon       Date:  2011-10       Impact factor: 0.660

3.  Response to single dose hepatitis B vaccine in Congolese non-HIV hemodialysis patients: a prospective observational study.

Authors:  Pitchou Yemasai Kengibe; Jean-Robert Risassy Makulo; Yannick Mayamba Nlandu; François Bompeka Lepira; Ernest Kiswaya Sumaili; Justine Busanga Bukabau; Charles Nlombi Mbendi; Steve Mundeke Ahuka; Antoine Wola Tshimpi; Patrick Kisoko Ngoma; Nseka Nazaire Mangani; Sebastien Nsukini Mbendi
Journal:  Pan Afr Med J       Date:  2019-10-31

4.  Clinical practice guideline management of blood borne viruses within the haemodialysis unit.

Authors:  Elizabeth Garthwaite; Veena Reddy; Sam Douthwaite; Simon Lines; Kay Tyerman; James Eccles
Journal:  BMC Nephrol       Date:  2019-10-28       Impact factor: 2.388

Review 5.  Spatial and temporal analyses to investigate infectious disease transmission within healthcare settings.

Authors:  G S Davis; N Sevdalis; L N Drumright
Journal:  J Hosp Infect       Date:  2014-02-26       Impact factor: 3.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.